April 23, 2020
HHSC has been informed of a drug shortage for Methylphenidate ER in the Stimulants drug class. VDP temporarily removed the non-preferred status from the brand formulations of the NDCs below on April 23. These changes will allow providers to prescribe for these drugs without requiring a PDL prior authorization and allow continued access to necessary medication for clients. This is a temporary change until the preferred products are sufficiently available in the market. VDP will announce any further PDL status changes of these NDCs. Contact vdp-formulary@hhsc.state.tx.us for more information.
NDC | Label Name |
50458058501 | CONCERTA ER 18 MG TABLET |
50458058601 | CONCERTA ER 36 MG TABLET |
50458058701 | CONCERTA ER 54 MG TABLET |
50458058801 | CONCERTA ER 27 MG TABLET |
Tags:
Drug
PDL